Previous Next Back To List
Search result: 33 of 96

(WO/2008/013963) FATTY ACID AMIDE HYDROLASE INHIBITORS

(WO/2008/013963) FATTY ACID AMIDE HYDROLASE INHIBITORS

Latest bibliographic data on file with the International Bureau
Pub. No.:  WO/2008/013963   International Application No.:  PCT/US2007/016953
Publication Date:31.01.2008 International Filing Date:27.07.2007
IPC: C07D 213/02 (2006.01), A61K 31/4245 (2006.01), A61K 31/425 (2006.01), A61K 31/44 (2006.01), C07C 233/02 (2006.01), C07D 271/06 (2006.01), C07D 277/02 (2006.01)
Applicants:UNIVERSITY OF CONNECTICUT [US/US]; 263 Farmington Avenue, Farmington, CT 06030-6207 (US) (All Except US).
MAKRIYANNIS, Alexandros [US/US]; (US) (US Only).
NIKAS, Spyridon, P. [GR/US]; (US) (US Only).
ALAPAFUJA, Shakiru, O. [NG/US]; (US) (US Only).
SHUKLA, Vidyanand, G. [IN/US]; (US) (US Only).
Inventors:MAKRIYANNIS, Alexandros; (US).
NIKAS, Spyridon, P.; (US).
ALAPAFUJA, Shakiru, O.; (US).
SHUKLA, Vidyanand, G.; (US).
Agent:PIOTROWSKI, James, E. et al.; Alix, Yale & Ristas, LLP, 750 Main Street - Suite 1400, Hartford, CT 06103-2721 (US).
Priority Data:
60/833,937 28.07.2006 US
Title: FATTY ACID AMIDE HYDROLASE INHIBITORS
Abstract: Disclosed are compounds of formula R-X-Y that may be used to inhibit the action of fatty acid amide hydrolase (FAAH). Inhibition of fatty acid amide hydrolase (FAAH) will slow the normal degradation and inactivation of endogenous cannabinoid ligands by FAAH hydrolysis and allow higher levels of those endogenous cannabinergic ligands to remain present. These higher levels of endocannabinoid ligands provide increased stimulation of the cannabinoid CBl and CB2 receptors and produce physiological effects related to the activation of the cannabinoid receptors. They will also enhance the effects of other exogenous cannabinergic ligands and allow them to produce their effects at lower concentrations as compared to systems in which fatty acid amide hydrolase (FAAH) action is not inhibited. Thus, a compound that inhibits the inactivation of endogenous cannabinoid ligands by fatty acid amide hydrolase (FAAH) may increase the levels of endocannabinoids and, thus, enhance the activation of cannabinoid receptors. Thus, the compound may not directly modulate the cannabinoid receptors but has the effect of indirectly stimulating the cannabinoid receptors by increasing the levels of endocannabinoid ligands. It may also enhance the effects and duration of action of other exogenous cannabinergic ligands that are administered in order to elicit a cannabinergic response.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Org. (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (EAPO) (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (OAPI) (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language:English (EN)
Filing Language:English (EN)

PATENTSCOPE®

Related Links

E-Newsletters